Vijaya Diagnostic Centre Ltd. (VIJAYA) fundamentals
Vijaya Diagnostic Centre Ltd. is a listed company in Healthcare Services, part of the Healthcare sector, listed on the NSE as VIJAYA (ISIN INE043W01024). This page carries its reported financials, balance sheet, cash flow, shareholding pattern and valuation ratios.
What Vijaya Diagnostic Centre Ltd. does
Vijaya Diagnostic Centre Limited is an India-based company, which is engaged in the business of providing a range of diagnostic services, spanning pathological investigations, basic and high-end radiology, nuclear medicine, and related healthcare services. It operates through the Diagnostic Services segment. It offers laboratory services and radiology services. Its services include clinical pathology, microbiology, hematology, serology, histopathology, cytogenetics, biochemistry, molecular diagnostics, computerized tomography (CT) scan, magnetic resonance imaging (MRI) scan, ultrasound, X-ray, cardiology, gastroenterology, nuclear medicine, and MRI-3T. It operates approximately 160 diagnostic centers in 25 cities spread across India. Its clinical pathology includes liver function test (LFT-A), creatine kinase (CPK) test, and thyroid profile test. It offers various health checkups, which include general wellness, women's care, gynecology packages, and lifestyle.
Valuation and market data
| Last close | ₹1400.00 |
|---|---|
| Market capitalisation | ₹14,406 crore |
| Enterprise value | ₹14,793 crore |
| P/E (TTM) | 83.28 |
| Price to book | 15.05 |
| Price to sales (TTM) | 9.79 |
| Book value per share | ₹93.01 |
| Dividend yield | 14.29% |
| Sector | Healthcare |
| Industry | Healthcare Services |
| Listed since | Tue Sep 14 |
Annual results
| Period | Revenue | Profit before tax | Net profit | EPS |
|---|---|---|---|---|
| Mar 2026 | ₹791 crore | ₹236 crore | ₹178 crore | 17.33 |
| Mar 2025 | ₹653 crore | ₹183 crore | ₹136 crore | 13.23 |
| Mar 2024 | ₹546 crore | ₹152 crore | ₹115 crore | 11.21 |
| Mar 2023 | ₹464 crore | ₹111 crore | ₹83 crore | 8.16 |
| Mar 2022 | ₹464 crore | ₹144 crore | ₹108 crore | 10.60 |
Figures are as reported (standalone), in ₹ crore.
Shareholding pattern
As of Sep 2026:
| Promoters | 52.5% |
|---|---|
| Foreign institutions (FII) | 10.7% |
| Mutual funds | 31.4% |
| Other domestic institutions | 1.1% |
| Retail and others | 4.4% |
More on BreakPoint
FundaX company research covers every listed company with reported financials. BreakPoint Pro adds the BreakPoint iQ score, the screener and the multibagger board.
Data is sourced from exchange filings and vendor feeds and is for research, not investment advice. Figures can be restated by the company after publication.